Literature DB >> 19161973

mitoEnergetics and cancer cell fate.

Zhi Xiong Chen1, Rathiga Velaithan, Shazib Pervaiz.   

Abstract

The critical role of mitochondria in cell fate decisions has been well documented over the years. These observations have highlighted the way mitochondrial physiology controls cell survival and growth in the normal settings, the critical role of mitochondrial outer membrane permeabilization and altered mitoenergetics in cell death execution, and most importantly the association of altered mitochondrial metabolism with pathological states, in particular cancer. Reprogramming of cell metabolism, an invariable finding in cancer cells, is tightly linked to mitoenergetics as is evidenced by up-regulation of nutrient uptake and a pro-oxidant tilt in the intracellular milieu. The latter has also been demonstrated in oncogene-induced carcinogenesis models, notably as a functional outcome of Bcl-2 overexpression. Interestingly, even in that model, mitochondria appear to be the target as well. Thus the association of metabolic re-circuiting and altered mitoenergetics with the process of transformation has resulted in a paradigm shift in the way cancer development and progression is viewed today, which has tremendous implications for the development of novel and strategic therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19161973     DOI: 10.1016/j.bbabio.2008.12.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis.

Authors:  Kristen P Nickens; Ying Han; Harini Shandilya; Ashley Larrimore; Gary F Gerard; Eric Kaldjian; Steven R Patierno; Susan Ceryak
Journal:  Biochim Biophys Acta       Date:  2011-10-25

2.  Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.

Authors:  Ubaldo E Martinez-Outschoorn; Renee M Balliet; Dayana B Rivadeneira; Barbara Chiavarina; Stephanos Pavlides; Chenguang Wang; Diana Whitaker-Menezes; Kristin M Daumer; Zhao Lin; Agnieszka K Witkiewicz; Neal Flomenberg; Anthony Howell; Richard G Pestell; Erik S Knudsen; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

3.  Life-history Constraints on the Mechanisms that Control the Rate of ROS Production.

Authors:  Juan Carlos Aledo
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

4.  Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo.

Authors:  Dmytro Starenki; Jong-In Park
Journal:  J Clin Endocrinol Metab       Date:  2013-03-18       Impact factor: 5.958

5.  Mitochondrial adaptations to oxidative stress confer resistance to apoptosis in lymphoma cells.

Authors:  Sarah T Wilkinson; Margaret E Tome; Margaret M Briehl
Journal:  Int J Mol Sci       Date:  2012-08-16       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.